ANIKAnika Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Anika Therapeutics, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIKThis | $279M#8 | — | 2.0x#4 | 2.5x#7 | -5.9%#13 | 80.4%#3 | -9.8%#7 | -8.0%#6 | -8.8%#5 | 4#8 | 141.0%#2 | — |
| CTSO | $360M#3 | — | — | 9.7x#13 | 4.1%#8 | 60.4%#4 | -39.8%#11 | — | -122.1%#12 | 4#8 | — | — |
| OBIO | $362M#2 | — | 3.6x#6 | 10.8x#14 | 1169.2%#1 | 13.6%#9 | -154.7%#14 | -52.8%#10 | -54.9%#11 | — | 151.1%#1 | 5.5%#2 |
| OFIX | $363M#1 | — | 0.8x#2 | 0.4x#2 | 2.9%#9 | 26.8%#7 | -9.9%#8 | -21.5%#8 | -14.9%#6 | 5#5 | -39.9%#5 | — |
| MOBI | $359M#4 | — | 2.1x#5 | — | — | — | — | 0.0%#5 | — | — | — | — |
| TLSI | $303M#5 | — | 46.3x#14 | 6.7x#12 | 53.4%#3 | -30.6%#14 | -59.7%#12 | -598.9%#14 | — | 5#5 | 3.7%#4 | — |
| TMCI | $296M#6 | — | 4.4x#8 | 1.4x#3 | 1.6%#10 | -5.8%#11 | -25.5%#10 | -87.1%#11 | -47.4%#10 | 2#12 | — | — |
| EMBC | $291M#7 | 3.5x#1 | — | 0.3x#1 | -3.8%#11 | 21.8%#8 | 22.4%#2 | — | 27.0%#1 | 6#3 | — | 12.0%#1 |
| INFU | $248M#9 | 31.2x#5 | 4.2x#7 | 1.7x#5 | 6.4%#7 | 182.6%#2 | 8.3%#5 | 11.2%#3 | 9.5%#4 | 9#1 | — | — |
| IDXG | $240M#11 | 9.9x#2 | 10.3x#11 | 6.2x#11 | -17.5%#14 | 267.2%#1 | 10.5%#4 | 105.8%#1 | 14.2%#3 | 5#5 | — | — |
| OSUR | $241M#10 | — | 0.8x#1 | 2.1x#6 | -38.1%#15 | -252.5%#15 | -62.6%#13 | -21.6%#9 | -43.8%#8 | — | 8.4%#3 | — |
| UTMD | $236M#12 | 22.6x#4 | 1.9x#3 | 6.1x#10 | -5.8%#12 | -18.7%#12 | 29.6%#1 | 9.2%#4 | — | — | — | 1.7%#3 |
| PDEX | $228M#13 | 17.3x#3 | 4.8x#9 | 2.9x#8 | 16.5%#5 | 52.2%#6 | 16.8%#3 | 28.7%#2 | 17.3%#2 | 7#2 | — | — |
| STIM | $212M#14 | — | 11.9x#12 | 1.4x#4 | 99.2%#2 | 10.8%#10 | -21.1%#9 | -218.5%#12 | -43.9%#9 | 3#10 | — | — |
| LUCD | $170M#15 | — | 15.6x#13 | 36.1x#15 | 8.3%#6 | -27.4%#13 | -1054.8%#15 | -530.9%#13 | — | 3#10 | — | — |
| KRMD | $148M#16 | — | 8.2x#10 | 3.6x#9 | 22.2%#4 | 56.5%#5 | -7.2%#6 | -14.6%#7 | -29.4%#7 | 6#3 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice